Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (41-50 of 270) with videos related to

Pageof 27
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2004
[Infection control in neutropenia induced by high-dose cytarabine chemotherapy]Masayuki Miyazaki, Kouji Senzaki, Hitoshi Kiyoi, et al.
Blood|May 27, 2011
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatmentEmi Goto, Akihiro Tomita, Fumihiko Hayakawa, et al.
International Journal of Hematology|December 5, 2002
Successful treatment with imatinib mesylate of a CML patient in megakaryoblastic crisis with severe fibrosisYuka Hirose, Hitoshi Kiyoi, Masanori Iwai, et al.
International Journal of Hematology|June 21, 2018
Impact of hospital length of stay on the risk of readmission and overall survival after allogeneic stem cell transplantationAika Seto, Yoshiko Atsuta, Naomi Kawashima, et al.
International Journal of Hematology|October 22, 2010
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatmentYosuke Minami, Tomohiro Kajiguchi, Akihiro Abe, et al.
International Journal of Hematology|July 3, 2020
Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphomaKoji Izutsu, Koji Kato, Hitoshi Kiyoi, et al.
Blood|July 5, 2003
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaYosuke Minami, Kazuhito Yamamoto, Hitoshi Kiyoi, et al.
Haematologica|April 12, 2012
Chimeric antisense RNA derived from chromosomal translocation modulates target gene expressionTakumi Sugimoto, Akihiro Tomita, Akihiro Abe, et al.
Oncogene|December 15, 2023
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemiaMina Noura, Hidemasa Matsuo, Takahiko Yasuda, et al.
Leukemia Research|November 12, 2017
Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndromeMizuho Shirahata-Adachi, Chisako Iriyama, Akihiro Tomita, et al.
Pageof 27

Showing results (41-50 of 270) with videos related to

Sort By:
Pageof 27
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2004
[Infection control in neutropenia induced by high-dose cytarabine chemotherapy]Masayuki Miyazaki, Kouji Senzaki, Hitoshi Kiyoi, et al.
Blood|May 27, 2011
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatmentEmi Goto, Akihiro Tomita, Fumihiko Hayakawa, et al.
International Journal of Hematology|December 5, 2002
Successful treatment with imatinib mesylate of a CML patient in megakaryoblastic crisis with severe fibrosisYuka Hirose, Hitoshi Kiyoi, Masanori Iwai, et al.
International Journal of Hematology|June 21, 2018
Impact of hospital length of stay on the risk of readmission and overall survival after allogeneic stem cell transplantationAika Seto, Yoshiko Atsuta, Naomi Kawashima, et al.
International Journal of Hematology|October 22, 2010
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatmentYosuke Minami, Tomohiro Kajiguchi, Akihiro Abe, et al.
International Journal of Hematology|July 3, 2020
Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphomaKoji Izutsu, Koji Kato, Hitoshi Kiyoi, et al.
Blood|July 5, 2003
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaYosuke Minami, Kazuhito Yamamoto, Hitoshi Kiyoi, et al.
Haematologica|April 12, 2012
Chimeric antisense RNA derived from chromosomal translocation modulates target gene expressionTakumi Sugimoto, Akihiro Tomita, Akihiro Abe, et al.
Oncogene|December 15, 2023
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemiaMina Noura, Hidemasa Matsuo, Takahiko Yasuda, et al.
Leukemia Research|November 12, 2017
Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndromeMizuho Shirahata-Adachi, Chisako Iriyama, Akihiro Tomita, et al.
Pageof 27